Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | 36982453 | PubTator, text mining | PubMed |
| Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience. | Genes (Basel) | 2023 | 36980947 | PubTator, text mining | PubMed |
| Progress toward Better Treatment of Therapy-Related AML. | Cancers (Basel) | 2023 | 36980546 | PubTator, text mining | PubMed |
| Computational and Functional Analysis of Structural Features in the ZAKα Kinase. | Cells | 2023 | 36980309 | PubTator, text mining | PubMed |
| In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation. | Cells | 2023 | 36980237 | PubTator, text mining | PubMed |
| Telomere Transcription in MLL-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy. | Biomedicines | 2023 | 36979904 | PubTator, text mining | PubMed |
| Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia. | Biomedicines | 2023 | 36979800 | PubTator, text mining | PubMed |
| De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients. | BMC Womens Health | 2023 | 36978050 | PubTator, text mining | PubMed |
| Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment. | Front Immunol | 2023 | 36960055 | PubTator, text mining | PubMed |
| Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. | Front Genet | 2023 | 36959829 | PubTator, text mining | PubMed |
| Systematic assessment of prognostic molecular features across cancers. | Cell Genom | 2023 | 36950380 | PubTator, text mining | PubMed |
| Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription. | Blood | 2023 | 36947815 | PubTator, text mining | PubMed |
| Sustained spontaneous remission in KMT2A-MLLT3 mutated myeloid sarcoma. | Ann Hematol | 2023 | 36930260 | PubTator, text mining | PubMed |
| Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype. | Cureus | 2023 | 36911590 | PubTator, text mining | PubMed |
| Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36902450 | PubTator, text mining | PubMed |
| Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target. | Int J Mol Sci | 2023 | 36902091 | PubTator, text mining | PubMed |
| Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. | Cancer Cell | 2023 | 36898380 | PubTator, text mining | PubMed |
| Identification of phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow based on single-cell RNA sequencing. | Elife | 2023 | 36876630 | PubTator, text mining | PubMed |
| Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia. | Front Pediatr | 2023 | 36873635 | PubTator, text mining | PubMed |
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study. | Haematologica | 2023 | 36861410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=14